Prostate Specific Antigen (PSA)

RSS | Login | Register

Survey: Leading Urologists Favor Routine PSA Tests

Stephan Cho October 31, 2011

Most leading urologists recommend routine PSA testing for men aged 50 and older, despite a recent U.S. panel's recommendation, according to a survey by U.S. News World & Report.

MRI Scans May Improve PCa Recurrence at Low PSA Levels

John Schieszer May 03, 2011

Dynamic contrast enhanced (DCE) endorectal magnetic resonance imaging (MRI) of the pelvis may offer an effective method of assessing for local recurrence of prostate cancer (PCa) after prostatectomy, according to Texas researchers.

High PSA Velocity Alone Is Not Enough Reason for Biopsy

Delicia Honen Yard March 29, 2011

An analysis of 5,519 men undergoing biopsy in the control arm of the Prostate Cancer Prevention Trial uncovered no evidence to support the recommendation that men with high PSA velocity be biopsied in the absence of other indications, according to an online report in the Journal of the National Cancer Institute.

PSA at Age 60 Predicts Prostate Cancer Death Risk

Jody A. Charnow October 01, 2010

PSA levels measured at age 60 predict a man's lifetime risk of metastasis and death from prostate cancer (PCa), according to a study published online in the British Medical Journal.

Baseline PSA Predicts Prostate Cancer Death Risk

Delicia Honen Yard September 24, 2010

Baseline PSA levels reliably and independently predicts death from prostate cancer, with a baseline reading of 4 ng/mL or higher linked with greater mortality risk.

Initial PSA Value After Salvage Cryoablation Predictive

Jody A. Charnow September 24, 2010

Initial PSA levels following salvage cryoabation in prostate cancer patients who failed radiation therapy may predict the likelihood of long-term biochemical progression, researchers found.

PSA Testing Found to Reduce Prostate Cancer Mortality

Delicia Honen Yard August 19, 2010

Deaths from prostate cancer (PCa) fell by almost half after 14 years of biennial screening, according to data from a Swedish study.

PSA Rises More Slowly with Age in Diabetics

Jody A. Charnow June 03, 2010

SAN FRANCISCO—Men with diabetes experience significantly smaller increases in PSA level as they age compared with non-diabetics, according to findings reported here at the American Urological Association Annual Meeting.

PSA Lower in Aspirin-Using Never Smokers

Jody A. Charnow April 01, 2010

Aspirin use is associated with lower PSA levels in men who have never smoked, data suggest.

PCA3 Beats PSA in Predicting Prostate Biopsy Outcomes

Jody A. Charnow March 05, 2010

SAN FRANCISCO—The prostate cancer gene 3 (PCA3) molecular urine test is more accurate than the PSA test in predicting outcomes of repeat biopsies, new findings confirm.

PSA Levels Decline After The Start of Statin Therapy

Jody A. Charnow January 15, 2010

Onset of statin use is associated with a significant reduction in serum PSA level, data suggest.

PSA Testing Rate Highest in Blacks

Jody A. Charnow December 15, 2009

A study of a large multiethnic cohort found that African-American men had a higher prevalence of PSA screening than white and Latino men.

Undetectable PSA Possible With Radiation

John Schieszer December 10, 2009

After a median of 32 months, PSA was undetectable in 12% of patients.

BMI Affects PSA Test Results in Whites

Jody A. Charnow September 18, 2009

The likelihood of an abnormal finding is 46% lower in obese men than normal-weight men, study shows

PSM Site Predicts PSA Relapse Risk

Jody A. Charnow September 17, 2009

Positive margins at the prostate base are associated with the worst outcomes.

Prostatic Urethral Lift Relieves Lower Urinary Tract Symptoms

Study: Electromagnetic Treatment Improves BPH

Epinephrine Can Cut TURP-Related Blood Loss

Never-Married Men Fare Worse After Prostate Cancer Surgery

Very Low Testosterone Hikes Prostate Cancer Recurrence Risk

Brachytherapy May Be An Option for Men with High-Risk Prostate Cancer

Legal Issues

Physician Sued For Failing to Follow Up

A primary care doctor referred a patient with an elevated PSA to a urologist. After a negative prostate biopsy, the doctor did not regularly conduct follow-up PSA testing, and the patient eventually died from prostate cancer.

Your Practice

Since its inception, health care providers have struggled with the need to protect patient privacy, share information, and keep paper work under control.

Read more on
Complying with HIPAA

Have any practice management topics that you'd like us to cover?
Let us know.